Edition:
United States

Business & Financial News, U.S & International Breaking News

Handout photo of vials of MPC-150-IM, MesoblastÕs stem cell product

Tiny stem cell firms close in on heart disease goals

Early stem cell therapy hopes have given way to a long list of failures. But two small companies are beginning final stage trials in hundreds of patients that could change the course of stroke and heart failure.

THE WIRE

More Top News

Wall St jumps on tax-cut hopes, M&A flurry

Major U.S. stock indexes hit record highs in a broad rally on Monday as the long-awaited bill to lower taxes looked set to be passed into law and a flurry of dealmaking buoyed sentiment.

Markets

STOCKS BONDS CURRENCIES COMMODITIES

Sponsored Content